☰

Okay Saydam - Publications

Affiliations: 
Medical University of Vienna, Wien, Wien, Austria 
Area:
miRNAs, microvesicles, medulloblastoma, meningioma, GBM
Tree Info Similar researchers PubMed Report error

30 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2022 Ampudia-Mesias E, El-Hadad S, Cameron CS, Wöhrer A, Ströbel T, Saydam N, Saydam O. SRPX Emerges as a Potential Tumor Marker in the Extracellular Vesicles of Glioblastoma. Cancers. 14. PMID 35454889 DOI: 10.3390/cancers14081984  0.313
2019 Erkan EP, Ströbel T, Dorfer C, Sonntagbauer M, Weinhäusel A, Saydam N, Saydam O. Circulating Tumor Biomarkers in Meningiomas Reveal a Signature of Equilibrium Between Tumor Growth and Immune Modulation. Frontiers in Oncology. 9: 1031. PMID 31649887 DOI: 10.3389/Fonc.2019.01031  0.353
2019 Erkan EP, Saydam N, Chen CC, Saydam O. Extracellular Vesicles as Carriers of Suicide mRNA and/or Protein in Cancer Therapy. Methods in Molecular Biology (Clifton, N.J.). 1895: 87-96. PMID 30539531 DOI: 10.1007/978-1-4939-8922-5_7  0.37
2017 Ströbel T, Madlener S, Tuna S, Vose S, Lagerweij T, Wurdinger T, Vierlinger K, Wöhrer A, Price BD, Demple B, Saydam O, Saydam N. Ape1 guides DNA repair pathway choice that is associated with drug tolerance in glioblastoma. Scientific Reports. 7: 9674. PMID 28852018 DOI: 10.1038/S41598-017-10013-W  0.363
2017 Senfter D, Erkan EP, Özer E, Jungwirth G, Madlener S, Kool M, Ströbel T, Saydam N, Saydam O. Overexpression of minichromosome maintenance protein 10 in medulloblastoma and its clinical implications Pediatric Blood & Cancer. 64. PMID 28598542 DOI: 10.1002/Pbc.26670  0.386
2017 Erkan EP, Senfter D, Madlener S, Jungwirth G, Ströbel T, Saydam N, Saydam O. Extracellular vesicle-mediated suicide mRNA/protein delivery inhibits glioblastoma tumor growth in vivo Cancer Gene Therapy. 24: 38-44. PMID 27982017 DOI: 10.1038/Cgt.2016.78  0.394
2015 Senol O, Schaaij-Visser TB, Erkan EP, Dorfer C, Lewandrowski G, Pham TV, Piersma SR, Peerdeman SM, Ströbel T, Tannous B, Saydam N, Slavc I, Knosp E, Jimenez CR, Saydam O. miR-200a-mediated suppression of non-muscle heavy chain IIb inhibits meningioma cell migration and tumor growth in vivo. Oncogene. 34: 1790-8. PMID 24858044 DOI: 10.1038/Onc.2014.120  0.319
2015 Stroebel T, Madlener S, Tuna S, Vose S, Morse D, Tannous BA, Lagerweij T, Wurdinger T, Marosi C, Slavc I, Vierlinger K, Saydam O, Price BD, Demple B, Saydam N. Abstract B26: Ape1/Ref-1 directs DNA repair pathway choice, linked to Chk2 signaling, critical for glioblastoma response to chemotherapy Clinical Cancer Research. 21. DOI: 10.1158/1557-3265.Pms14-B26  0.368
2014 Erkan EP, Ströbel T, Lewandrowski G, Tannous B, Madlener S, Czech T, Saydam N, Saydam O. Depletion of minichromosome maintenance protein 7 inhibits glioblastoma multiforme tumor growth in vivo. Oncogene. 33: 4778-85. PMID 24166506 DOI: 10.1038/Onc.2013.423  0.364
2013 Madlener S, Ströbel T, Vose S, Saydam O, Price BD, Demple B, Saydam N. Essential role for mammalian apurinic/apyrimidinic (AP) endonuclease Ape1/Ref-1 in telomere maintenance. Proceedings of the National Academy of Sciences of the United States of America. 110: 17844-9. PMID 24127576 DOI: 10.1073/Pnas.1304784110  0.353
2013 Mizrak A, Bolukbasi MF, Ozdener GB, Brenner GJ, Madlener S, Erkan EP, Ströbel T, Breakefield XO, Saydam O. Genetically engineered microvesicles carrying suicide mRNA/protein inhibit schwannoma tumor growth. Molecular Therapy : the Journal of the American Society of Gene Therapy. 21: 101-8. PMID 22910294 DOI: 10.1038/Mt.2012.161  0.417
2012 Saydam O, Glauser DL, Fraefel C. Construction and packaging of herpes simplex virus/adeno-associated virus (HSV/AAV) Hybrid amplicon vectors. Cold Spring Harbor Protocols. 2012: 352-6. PMID 22383640 DOI: 10.1101/Pdb.Prot068114  0.341
2011 Erkan EP, Breakefield XO, Saydam O. miRNA signature of schwannomas: possible role(s) of "tumor suppressor" miRNAs in benign tumors. Oncotarget. 2: 265-70. PMID 21454924 DOI: 10.18632/Oncotarget.251  0.336
2011 Saydam O, Senol O, Würdinger T, Mizrak A, Ozdener GB, Stemmer-Rachamimov AO, Yi M, Stephens RM, Krichevsky AM, Saydam N, Brenner GJ, Breakefield XO. miRNA-7 attenuation in Schwannoma tumors stimulates growth by upregulating three oncogenic signaling pathways. Cancer Research. 71: 852-61. PMID 21156648 DOI: 10.1158/0008-5472.Can-10-1219  0.357
2011 Saydam O, Ozdener GB, Senol O, Mizrak A, Prabhakar S, Stemmer-Rachamimov AO, Breakefield XO, Brenner GJ. A novel imaging-compatible sciatic nerve schwannoma model. Journal of Neuroscience Methods. 195: 75-7. PMID 21111000 DOI: 10.1016/J.Jneumeth.2010.10.021  0.339
2010 Saydam O, Senol O, Schaaij-Visser TB, Pham TV, Piersma SR, Stemmer-Rachamimov AO, Wurdinger T, Peerdeman SM, Jimenez CR. Comparative protein profiling reveals minichromosome maintenance (MCM) proteins as novel potential tumor markers for meningiomas. Journal of Proteome Research. 9: 485-94. PMID 19877719 DOI: 10.1021/Pr900834H  0.391
2009 Saydam O, Shen Y, Würdinger T, Senol O, Boke E, James MF, Tannous BA, Stemmer-Rachamimov AO, Yi M, Stephens RM, Fraefel C, Gusella JF, Krichevsky AM, Breakefield XO. Downregulated microRNA-200a in meningiomas promotes tumor growth by reducing E-cadherin and activating the Wnt/beta-catenin signaling pathway. Molecular and Cellular Biology. 29: 5923-40. PMID 19703993 DOI: 10.1128/Mcb.00332-09  0.33
2009 Tannous BA, Christensen AP, Pike L, Wurdinger T, Perry KF, Saydam O, Jacobs AH, García-Añoveros J, Weissleder R, Sena-Esteves M, Corey DP, Breakefield XO. Mutant sodium channel for tumor therapy. Molecular Therapy : the Journal of the American Society of Gene Therapy. 17: 810-9. PMID 19259066 DOI: 10.1038/Mt.2009.33  0.38
2008 Würdinger T, Tannous BA, Saydam O, Skog J, Grau S, Soutschek J, Weissleder R, Breakefield XO, Krichevsky AM. miR-296 regulates growth factor receptor overexpression in angiogenic endothelial cells. Cancer Cell. 14: 382-93. PMID 18977327 DOI: 10.1016/J.Ccr.2008.10.005  0.332
2008 Cortés ML, Oehmig A, Saydam O, Sanford JD, Perry KF, Fraefel C, Breakefield XO. Targeted integration of functional human ATM cDNA into genome mediated by HSV/AAV hybrid amplicon vector. Molecular Therapy : the Journal of the American Society of Gene Therapy. 16: 81-8. PMID 17998902 DOI: 10.1038/Sj.Mt.6300338  0.374
2007 Saydam O, Saydam N, Glauser DL, Pruschy M, Dinh-Van V, Hilbe M, Jacobs AH, Ackermann M, Fraefel C. HSV-1 amplicon-mediated post-transcriptional inhibition of Rad51 sensitizes human glioma cells to ionizing radiation. Gene Therapy. 14: 1143-51. PMID 17495946 DOI: 10.1038/Sj.Gt.3302967  0.385
2007 Glauser DL, Strasser R, Laimbacher AS, Saydam O, Clément N, Linden RM, Ackermann M, Fraefel C. Live covisualization of competing adeno-associated virus and herpes simplex virus type 1 DNA replication: molecular mechanisms of interaction. Journal of Virology. 81: 4732-43. PMID 17314170 DOI: 10.1128/Jvi.02476-06  0.364
2006 Glauser DL, Ackermann M, Saydam O, Fraefel C. Chimeric herpes simplex virus/adeno-associated virus amplicon vectors. Current Gene Therapy. 6: 315-24. PMID 16787183 DOI: 10.2174/156652306777592090  0.353
2006 Saydam O, Steiner F, Vogt B, Schwyzer M. Host cell targets of immediate-early protein BICP22 of bovine herpesvirus 1. Veterinary Microbiology. 113: 185-92. PMID 16352405 DOI: 10.1016/J.Vetmic.2005.11.046  0.35
2005 Glauser DL, Saydam O, Balsiger NA, Heid I, Linden RM, Ackermann M, Fraefel C. Four-dimensional visualization of the simultaneous activity of alternative adeno-associated virus replication origins. Journal of Virology. 79: 12218-30. PMID 16160148 DOI: 10.1128/Jvi.79.19.12218-12230.2005  0.359
2005 Saydam O, Glauser DL, Heid I, Turkeri G, Hilbe M, Jacobs AH, Ackermann M, Fraefel C. Herpes simplex virus 1 amplicon vector-mediated siRNA targeting epidermal growth factor receptor inhibits growth of human glioma cells in vivo. Molecular Therapy : the Journal of the American Society of Gene Therapy. 12: 803-12. PMID 16112910 DOI: 10.1016/J.Ymthe.2005.07.534  0.368
2005 Müller L, Saydam O, Saeki Y, Heid I, Fraefel C. Gene transfer into hepatocytes mediated by herpes simplex virus-Epstein-Barr virus hybrid amplicons. Journal of Virological Methods. 123: 65-72. PMID 15582700 DOI: 10.1016/J.Jviromet.2004.09.007  0.332
2005 Saydam O, Glauser D, Heid I, Turkeri G, Jacobs A, Ackermann M, Fraefel C. 724. Herpes Simplex Virus 1 Amplicon Vector-Mediated siRNA Targeting Epidermal Growth Factor Receptor Inhibits Growth of Human Glioma Cells in Culture and In Vivo Molecular Therapy. 11. DOI: 10.1016/J.Ymthe.2005.07.264  0.371
2004 Saydam O, Abril C, Vogt B, Ackermann M, Schwyzer M. Transactivator protein BICP0 of bovine herpesvirus 1 (BHV-1) is blocked by prostaglandin D2 (PGD2), which points to a mechanism for PGD2-mediated inhibition of BHV-1 replication. Journal of Virology. 78: 3805-10. PMID 15047795 DOI: 10.1128/Jvi.78.8.3805-3810.2004  0.383
2002 Saydam O, Vogt B, Ackermann M, Schwyzer M. Search for physical interaction between BICP0 of bovine herpesvirus-1 and p53 tumor suppressor protein. Veterinary Microbiology. 86: 95-102. PMID 11888693 DOI: 10.1016/S0378-1135(01)00494-1  0.35
Show low-probability matches.